| NCT ID | NCT03457402 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Impulsivity |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2017-09-12 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2017-09-12 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Deficits in self-control are of major public health relevance as they contribute to several negative outcomes for both individuals and society. For children, developing self-control is a critically important step toward success in academic settings and social relationships, yet there are few non-pharmacological approaches that have been successful in increasing self-control. We found in our earlier studies that self-control can be increased in preschool-aged children with high impulsivity by using games in which they practice gradually increasing wait-time for larger, more delayed rewards. We are performing this current study to test if this training to increase self-control can be increased using mobile app technology, with computerized game time being used as a reward.
Eligibility Criteria
Inclusion Criteria: * Age 3-6 years * Hyperactivity/Impulsivity subscale scores of the ADHD Rating Scale-IV Preschool Version (children 3 to 4 years of age) or the Attention and Behavior Scale (children 5 to 6 years of age) ≥ 90th percentile from either the parent or teacher's responses * Physically and visually able to use the tablet, as determined by pre-assessment performance * Children taking psychotropic medication will be included, but must maintain the same medication and dose over the course of the study and for each assessment and exhibit elevated levels of impulsivity based on parent or teacher ratings while medicated. Exclusion Criteria: * Children with autism spectrum disorder and/or intellectual disability (by parent or teacher report or the NIH Toolbox Picture Vocabulary Test).
Contact & Investigator
Julie Schweitzer, Ph.D.
PRINCIPAL INVESTIGATOR
UC Davis MIND Institute
Frequently Asked Questions
Who can join the NCT03457402 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Impulsivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03457402 currently recruiting?
Yes, NCT03457402 is actively recruiting participants. Contact the research team at hs-airlab@ucdavis.edu for enrollment information.
Where is the NCT03457402 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT03457402 clinical trial?
NCT03457402 is sponsored by University of California, Davis. The principal investigator is Julie Schweitzer, Ph.D. at UC Davis MIND Institute. The trial plans to enroll 50 participants.